GSK sells par­tial stake of con­sumer health spin­off Ha­le­on for $1.2B

GSK is sell­ing off more of its stake in con­sumer health spin­off Ha­le­on for about $1.2 bil­lion, ac­cord­ing to a se­cu­ri­ties fil­ing.

The phar­ma gi­ant said Thurs­day in a state­ment to End­points News that the sale — its third — is part of a “dis­ci­plined and prag­mat­ic ap­proach” to di­vest­ing its stake, and fur­ther di­vesti­ture is “de­pen­dent on mar­ket con­di­tions.”

The com­pa­ny an­nounced Wednes­day that it’s sell­ing 300 mil­lion shares in Ha­le­on, rais­ing about £978 mil­lion. That leaves GSK with a 4.2% stake, down from about 13% in 2022, when Ha­le­on was spun out.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER